欧盟委员会批准罗氏Lunsumio皮下注射剂用于复发或难治性滤泡性淋巴瘤——雅虎财经

European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma  Yahoo Finance